High diversity of clinical Mycobacterium intracellulare in China revealed by whole genome sequencing [PDF]
Frontiers in Public Health, 2022 Mycobacterium intracellulare is the most common cause of nontuberculous mycobacterial lung disease, with a rapidly growing prevalence worldwide. In this study, we performed comparative genomic analysis and antimicrobial susceptibility characteristics ...
Zexuan Song +12 more
doaj +2 more sources
A rare presentation of Legionella pneumophila and Mycobacterium intracellulare co‐infection masquerading as metastatic lung cancer in a patient with positive anti‐interferon gamma antibody [PDF]
Respirology Case Reports, 2023 Adult‐onset immunodeficiency (AOID) syndrome due to the presence of anti‐interferon gamma antibody (AIGA) is characterized by multiple opportunistic infections.
Hei‐Shun Cheng +4 more
doaj +2 more sources
Genomic insights and functional adaptation of Mycobacterium intracellulare strains isolated from patients with inflammatory bowel disease [PDF]
Microbiology SpectrumIn clinical practice, inappropriate diagnosis of inflammatory bowel disease (IBD) ascribing the disease to Mycobacterium avium paratuberculosis (MAP) and resulting mistreatment has been a challenge for healthcare workers.
Sushanta Deb +6 more
doaj +2 more sources
Feature of Adhesins Produced by Human Clinical Isolates of Mycobacterium intracellulare, Mycobacterium intracellulare subsp. chimaera and Closely Related Species [PDF]
Microorganisms, 2020 The Mycobacterium avium complex includes two closely related species, Mycobacterium avium and Mycobacterium intracellulare. They are opportunistic pathogens in humans and responsible for severe disease in a wide variety of animals.
Louise H. Lefrancois +8 more
doaj +2 more sources
Virulence of Mycobacterium intracellulare clinical strains in a mouse model of lung infection – role of neutrophilic inflammation in disease severity [PDF]
BMC Microbiology, 2023 Background Mycobacterium intracellulare is a major etiological agent of Mycobacterium avium-intracellulare pulmonary disease (MAC-PD). However, the characteristics of the virulence of M.
Yoshitaka Tateishi +6 more
doaj +2 more sources
Differences in Drug-Susceptibility Patterns between Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium chimaera Clinical Isolates: Prospective 8.5-Year Analysis by Three Laboratories [PDF]
Antibiotics, 2022 Background: It has been suggested that Mycobacterium avium, Mycobacterium intracellulare, and M. chimaera have differential drug susceptibility patterns.
Mariana Fernandez-Pittol +12 more
doaj +2 more sources
A case of axillary lymphadenitis caused by Mycobacterium intracellulare in an immunocompetent patient [PDF]
Respiratory Medicine Case Reports, 2019 Axillary lymphadenitis caused by non-tuberculous mycobacteria is rare and has been reported in immunocompromised hosts. Herein, we report the case of a 67-year-old man without immunodeficiency who developed right axillary lymphadenitis caused by ...
Junko Itano +8 more
doaj +2 more sources
A novel repeat sequence-based PCR (rep-PCR) using specific repeat sequences of Mycobacterium intracellulare as a DNA fingerprinting [PDF]
Frontiers in Microbiology, 2023 Repetitive sequence-based PCR (rep-PCR) is a potential epidemiological technique that can provide high-throughput genotype fingerprints of heterogeneous Mycobacterium strains rapidly.
Jeong-Ih Shin +20 more
doaj +2 more sources
Mycobacterium intracellulare subsp. chimaera from Cardio Surgery Heating-Cooling Units and from Clinical Samples in Israel Are Genetically Unrelated [PDF]
Pathogens, 2021 Non-tuberculous mycobacteria (NTM) are opportunistic pathogens that cause illness primarily in the elderly, in the immunocompromised or in patients with underlying lung disease.
Mor Rubinstein +7 more
doaj +2 more sources
Functional genomics reveals strain-specific genetic requirements conferring hypoxic growth in Mycobacterium intracellulare [PDF]
eLifeMycobacterium intracellulare is a major etiological agent of the recently expanding Mycobacterium avium–intracellulare complex pulmonary disease (MAC-PD).
Yoshitaka Tateishi +6 more
doaj +2 more sources